Reading is good for you...
Reading about what's good for you is even better.
August 8, 2022
August 10, 2022
August 2, 2022
Get your Entocort Rectal delivered at your door for FREE
Tillotts Pharma GMBH
Budesonide belongs to the class of medications called glucocorticosteroids. Budesonide enemas are used to treat diseases caused by inflammation of the colon and rectum, such as certain types of Ulcerative Colitis that involve the rectum, sigmoid, and descending colon.
We accept all insurance plans
**Actual price will depend on the insurance coverage in your province
Budesonide belongs to the class of medications called glucocorticosteroids. Budesonide enemas are used to treat diseases caused by inflammation of the colon and rectum, such as certain types of Ulcerative Colitis that involve the rectum, sigmoid, and descending colon. It works within the colon and rectum to decrease inflammation.
Entocort Rectal (Budesonide-rectal) may be available under multiple brand names and/or in several different forms. Any specific brand name of Entocort Rectal (Budesonide-rectal) may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of Entocort Rectal (Budesonide-rectal) may not be used for all of the conditions discussed here.
Your doctor may have suggested Entocort Rectal (Budesonide-rectal) for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking Entocort Rectal (Budesonide-rectal), speak to your doctor. Do not stop taking Entocort Rectal (Budesonide-rectal) without consulting your doctor.
Do not give Entocort Rectal (Budesonide-rectal) to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take Entocort Rectal (Budesonide-rectal) if their doctor has not prescribed it.
The usual adult dose of budesonide enema is the contents of one 115 mL enema nightly, at bedtime, for 4 weeks. If necessary, the treatment period may be lengthened to 8 weeks.
To prepare the medication:
To use the medication:
Many things can affect the dose of a medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are using the medication without consulting your doctor.
It is important to use Entocort Rectal (Budesonide-rectal) exactly as prescribed by your doctor.
If you miss a dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.
Store Entocort Rectal (Budesonide-rectal) at room temperature, protect it from light and moisture, and keep it out of the reach of children.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Entocort Rectal (Budesonide-rectal). If you are concerned about side effects, discuss the risks and benefits of Entocort Rectal (Budesonide-rectal) with your doctor.
The following side effects have been reported by at least 1% of people taking Entocort Rectal (Budesonide-rectal). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Entocort Rectal (Budesonide-rectal).
Each budesonide enema 0.02 mg/mL consists of 2 components: a dispersible tablet and an applicator bottle of vehicle solution.
Each dispersible tablet contains 2.3 mg of micronized budesonide. Nonmedicinal ingredients: colloidal silicon dioxide, lactose, lactose anhydrous, magnesium stearate, cross-linked polyvidone, and riboflavin-5-phosphate sodium.
The vehicle is a solution containing methylparaben, propylparaben, sodium chloride, and purified water.
Do not use Entocort Rectal (Budesonide-rectal) if you:
There may be an interaction between budesonide and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Entocort Rectal (Budesonide-rectal). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Entocort Rectal (Budesonide-rectal).
General precautions: Advise all doctors involved in your care that you have been using Entocort Rectal (Budesonide-rectal). If you have been taking "cortisone" tablets, your doctor may want you to discontinue the tablet form of the medication. Much less corticosteroid is absorbed from budesonide enemas, so stopping the tablets should be done gradually to reduce the likelihood of withdrawal symptoms such as tiredness, headache, nausea, or vomiting.
Medical conditions: People with Diabetes, Glaucoma, liver disease, Osteoporosis, or stomach ulcers should discuss with their doctor how this medication may affect their medical condition, how their medical condition may affect the dosing and effectiveness of Entocort Rectal (Budesonide-rectal), and whether any special monitoring is needed.
Severe bowel disease: People with severe ulcerative disease of the bowel should use Entocort Rectal (Budesonide-rectal) with caution, as they are susceptible to perforation of the bowel wall. If you have severe ulcerative disease, discuss with your doctor how Entocort Rectal (Budesonide-rectal) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Entocort Rectal (Budesonide-rectal), and whether any special monitoring is needed.
Stopping medication: Stopping Entocort Rectal (Budesonide-rectal) suddenly may cause symptoms of the illness to return. Do not stop using Entocort Rectal (Budesonide-rectal) abruptly without checking with your doctor first.
Pregnancy: Entocort Rectal (Budesonide-rectal) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while using Entocort Rectal (Budesonide-rectal), contact your doctor immediately.
Breastfeeding: Entocort Rectal (Budesonide-rectal) passes into breast milk. If you are a breast-feeding mother and are using budesonide enemas, it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of budesonide enemas have not been established for children.
All material © 1996-2021 MediResource Inc. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.
August 8, 2022
August 10, 2022
August 2, 2022